XML 52 R28.htm IDEA: XBRL DOCUMENT v3.25.4
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION
 12 Months Ended
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION
For the presentation of the parent company only condensed financial information, the Company records its investments in subsidiaries under the equity method of accounting as prescribed in ASC 323, Investments—Equity Method and Joint Ventures. Such investments are presented on the condensed balance sheets as “Investment in consolidated subsidiaries and equity method investees” and the subsidiaries’ losses and gains as “Equity in earnings of consolidated subsidiaries and equity method investees” on the condensed statements of comprehensive income. Certain information and footnote disclosures generally included in the financial statements prepared in accordance with GAAP have been condensed or omitted. The footnote disclosure contains supplemental information relating to the operations of ACM separately.
ACM Shanghai paid a dividend to ACM Research during the years ended December 31, 2025, 2024, and 2023 (note 2).
Except for long-term obligations, or guarantees, and a loan borrowed by ACM Inc. from China CITIC Bank (note 10), ACM does not have significant capital or other commitments, as of December 31, 2025 or 2024.
The following represents condensed unconsolidated financial information of ACM Research only as of December 31, 2025 and 2024, and for the years ended December 31, 2025, 2024 and 2023:
CONDENSED BALANCE SHEETS
December 31,
20252024
Assets
Current assets:
Cash and cash equivalents$96,184 $54,764 
Account receivables, net84 2 
Due from intercompany8,457 6,554 
Other receivables 11,595 8,938 
Prepaid expenses and other current assets 417 479 
Total current assets116,737 70,737 
    Deferred tax assets5,246 4,610 
    Property, plant and equipment, net 8,482 7,990 
    Investment in consolidated subsidiaries and equity method investees 1,376,596 844,507 
Total assets$1,507,061 $927,844 
Liabilities and Stockholders’ Equity
    Short-term borrowings$28,346 $13,882 
    Accounts payable 709 391 
    Other payables and accrued expenses
10,456 8,098 
    Income taxes payable240 — 
    FIN-48 payable2,833 848 
       Total current liabilities42,584 23,219 
     Long-term borrowings114— 
Total liabilities42,698 23,219 
Total stockholders’ equity1,464,363 904,625 
Total liabilities and stockholders' equity$1,507,061 $927,844 
CONDENSED STATEMENTS OF OPERATIONS
Year Ended December 31,
202520242023
Revenue$7,704 $2,576 $6,354 
Cost of revenue(4,590)(132)(4,336)
Gross profit3,114 2,444 2,018 
Operating expenses:
Sales and marketing expenses(9,461)(6,909)(4,715)
General and administrative expenses(13,218)(10,331)(7,840)
Loss from operations(19,565)(14,796)(10,537)
Equity in earnings of consolidated subsidiaries and equity method investees85,129 87,916 73,707 
Interest income, net3,428 2,094 799 
Interest expense, net(1,443)(560)(66)
Other income, net34,526 34,684 18,476 
Income before income taxes102,075 109,338 82,379 
Income tax expense(7,997)(5,711)(5,030)
Net income94,078 103,627 77,349 
Foreign currency translation adjustment, net of tax25,848 (14,373)(8,803)
Unrealized gain on available-for-sale investments, net of tax1,784 350 — 
Comprehensive income attributable to ACM Research, Inc.$121,710 $89,604 $68,546 
CONDENSED STATEMENTS OF CASH FLOWS
Year Ended December 31,
202520242023
Net cash (used in) provided by operating activities$7,555 $15,285 $1,489 
Net cash used in investing activities(724)(7,889)(149)
Net cash provided by financing activities34,589 5,752 16,423 
Net increase (decrease) in cash and cash equivalents41,420 13,148 17,763 
Cash and cash equivalents, beginning of year54,764 41,616 23,853 
Cash and cash equivalents, end of year$96,184 $54,764 $41,616